leflunomide has been researched along with SAPHO Syndrome in 2 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cornillier, H | 1 |
| Kervarrec, T | 1 |
| Tabareau-Delalande, F | 1 |
| Mammou, S | 1 |
| Jonville Bera, AP | 1 |
| Machet, L | 1 |
| Zhao, Z | 1 |
| Li, Y | 2 |
| Zhao, H | 1 |
| Li, H | 1 |
1 review available for leflunomide and SAPHO Syndrome
| Article | Year |
|---|---|
Synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome with review of the relevant published work.
Topics: Acquired Hyperostosis Syndrome; Adult; Dermatologic Agents; Diagnosis, Differential; Female; Hand De | 2011 |
1 other study available for leflunomide and SAPHO Syndrome
| Article | Year |
|---|---|
Interstitial granulomatous dermatitis occurring in a patient with SAPHO syndrome one month after starting leflunomide, and subsequently disappearing with ustekinumab.
Topics: Acquired Hyperostosis Syndrome; Adult; Dermatitis; Dermatologic Agents; Drug Eruptions; Female; Gran | 2016 |